Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma

Anja Müller(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christian Schölz(Vivantes Klinikum)

International Journal of Cancer

April 12, 2013

10.1002/ijc.28206

Cited by 46

Related Papers

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

|BMC Cancer|2017|226

Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53

|Cell Death and Disease|2018|13

Histone deacetylase inhibitors butyrate and bufexamac inhibit <i>de novo</i> HIV-1 infection in CD4 T-cells

|bioRxiv (Cold Spring Harbor Laboratory)|2020|0

110 | HIGH PFS WITH LOW INFIELD RECURRENCES AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE NODAL FOLLICULAR LYMPHOMA: FINAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3)

|Hematological Oncology|2025|0